Selected Balance Sheet Data (Tables)
|
3 Months Ended |
Sep. 30, 2025 |
|---|
| Notes Tables |
|
| Schedule of inventories |
Inventories consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
September 30, |
|
June 30, |
|
|
|
2025 |
|
2025 |
|
Raw materials |
|
$ |
93,993 |
|
$ |
89,080 |
|
Finished goods(1) |
|
|
114,878 |
|
|
106,188 |
|
Inventories |
|
$ |
208,871 |
|
$ |
195,268 |
|
| (1) |
Finished goods inventory of $5,683 and $5,822 is included within Other Assets in the September 30, 2025 and June 30, 2025, Condensed Consolidated Balance Sheets, respectively, as it is forecasted to be sold after the 12 months subsequent to the Condensed Consolidated Balance Sheets dates.
|
|
| Schedule of property and equipment |
Property and equipment consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
September 30, |
|
June 30, |
|
|
|
2025 |
|
2025 |
|
Land |
|
$ |
8,133 |
|
$ |
8,151 |
|
Buildings and improvements |
|
|
256,737 |
|
|
254,355 |
|
Machinery and equipment |
|
|
244,188 |
|
|
245,924 |
|
Construction in progress |
|
|
20,257 |
|
|
23,420 |
|
Property and equipment, cost |
|
|
529,315 |
|
|
531,850 |
|
Accumulated depreciation and amortization |
|
|
(288,981) |
|
|
(286,131) |
|
Property and equipment, net |
|
$ |
240,334 |
|
$ |
245,719 |
|
|
| Schedule of intangible assets |
Intangible assets consist of (in thousands):
|
|
|
|
|
|
|
|
September 30, |
|
June 30, |
|
|
2025 |
|
2025 |
|
Developed technology |
$ |
579,531 |
|
$ |
620,062 |
|
Tradenames |
|
94,393 |
|
|
152,648 |
|
Customer relationships |
|
210,431 |
|
|
212,800 |
|
Patents |
|
5,062 |
|
|
4,967 |
|
Other intangibles |
|
7,145 |
|
|
7,174 |
|
Definite-lived intangible assets |
|
896,562 |
|
|
997,651 |
|
Accumulated amortization |
|
(546,455) |
|
|
(632,052) |
|
Total intangible assets, net |
$ |
350,107 |
|
$ |
365,599 |
|
|
| Schedule of changes in carrying amount of net intangible assets |
Changes to the carrying amount of net intangible assets for the period ended September 30, 2025 consist of (in thousands):
|
|
|
|
|
|
September 30, |
|
|
2025 |
Beginning balance |
|
$ |
365,599 |
Other additions |
|
|
95 |
Amortization expense |
|
|
(15,498) |
Currency translation |
|
|
(89) |
Ending balance |
|
$ |
350,107 |
|
| Schedule of estimated future amortization expense for intangible assets |
The estimated future amortization expense for intangible assets as of September 30, 2025 is as follows (in thousands):
|
|
|
|
Remainder 2026 |
|
$ |
46,256 |
2027 |
|
|
58,682 |
2028 |
|
|
54,951 |
2029 |
|
|
40,870 |
2030 |
|
|
26,911 |
Thereafter |
|
|
122,437 |
Total |
|
$ |
350,107 |
|
| Schedule of changes to the carrying amount of goodwill |
Changes to the carrying amount of goodwill for the period ended September 30, 2025 consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics and |
|
|
|
|
Protein Sciences |
|
Spatial Biology |
|
Total |
June 30, 2025 |
|
$ |
426,776 |
|
$ |
554,159 |
|
$ |
980,935 |
Currency translation |
|
|
(1,975) |
|
|
(48) |
|
|
(2,023) |
September 30, 2025 |
|
$ |
424,801 |
|
$ |
554,111 |
|
$ |
978,912 |
|
| Schedule of other assets |
Other assets:
Other assets consist of (in thousands):
|
|
|
|
|
|
|
|
|
September 30, |
|
June 30, |
|
|
2025 |
|
2025 |
Equity method investment in Wilson Wolf |
|
$ |
234,925 |
|
$ |
235,983 |
Long-term inventory |
|
|
5,683 |
|
|
5,822 |
Investment in Spear Bio |
|
|
15,000 |
|
|
15,000 |
Investment in MDxHealth(1) |
|
|
8,682 |
|
|
— |
Notes receivable(1) |
|
|
7,744 |
|
|
2,184 |
Other |
|
|
4,529 |
|
|
24,927 |
Other assets |
|
$ |
276,563 |
|
$ |
283,916 |
|
(1) |
Amounts relate to the completed divestitures of the Company’s held-for-sale assets. |
|